Ariceum Therapeutics and NorthStar Medical Radioisotopes Announce Supply Agreement for Therapeutic Radioisotope Actinium-225

ATNM Stock  USD 1.34  0.02  1.52%   
About 50% of Actinium Pharmaceuticals' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Actinium Pharmaceuticals suggests that some traders are interested. Actinium Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Actinium Pharmaceuticals. Many technical investors use Actinium Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
PRNewswire -- Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain...

Read at prnewswire.com
prnewswire News
  

Actinium Pharmaceuticals Fundamental Analysis

We analyze Actinium Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Actinium Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Actinium Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Institutions

Shares Owned By Institutions Comparative Analysis

Actinium Pharmaceuticals is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Actinium Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Actinium Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Actinium Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Actinium Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Actinium Pharmaceuticals Related Equities

RNAZTranscode Therapeutics   57.59   
0%
100.0%
RVPHWReviva Pharmaceuticals   5.56   
0%
9.0%
BTAIBioXcel Therapeutics   5.56   
0%
9.0%
MDGLMadrigal Pharmaceuticals   4.75   
0%
8.0%
EXELExelixis   3.80   
0%
6.0%
SGMOSangamo Therapeutics   3.48   
0%
6.0%
KODKodiak Sciences   3.10   
0%
5.0%
VKTXViking Therapeutics   2.61   
0%
4.0%
CGTXCognition Therapeutics   2.60   
0%
4.0%
ADAPAdaptimmune Therapeutics   1.75   
0%
3.0%
AXSMAxsome Therapeutics   1.58   
0%
2.0%
RIGLRigel Pharmaceuticals   1.51   
0%
2.0%
AFMDAffimed NV   0.91   
0%
1.0%
TGTXTG Therapeutics   0.34   
1.0%
0%
SAVACassava Sciences   1.15   
1.0%
0%
MCRBSeres Therapeutics   2.20   
3.0%
0%
RVPHReviva Pharmaceuticals   2.58   
4.0%
0%
FBIOFortress Biotech   2.69   
4.0%
0%
INKTMink Therapeutics   2.97   
5.0%
0%
ANVSAnnovis Bio   3.77   
6.0%
0%
When determining whether Actinium Pharmaceuticals is a strong investment it is important to analyze Actinium Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Actinium Pharmaceuticals' future performance. For an informed investment choice regarding Actinium Stock, refer to the following important reports:
Check out Actinium Pharmaceuticals Hype Analysis, Actinium Pharmaceuticals Correlation and Actinium Pharmaceuticals Performance.
To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.
You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.